Although there was a trend towards significance for the association between low SII and high SII at 3‐, 5‐ and 10‐year rates, there were no significant differences between the two groups.
← all excerpts
Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy.
1
—
—